Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

Recruiting now · Not applicable

Conditions studied: Acute Lymphoblastic Leukemia, Pediatric

In brief

The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.

Key facts

Study ID

NCT06074666

Run by

Roswell Park Cancer Institute

People needed

100

Starts

2024-11-07

Expected to finish

2027-10-01

Last updated by the study team

2026-04-23

Who can join

Age: 3 and older, up to 9. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Parent of a child who is diagnosed and being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
• Parent has primary medication responsibility.
• Pediatric patient aged 3-9 years
• Child on therapy that includes home-based oral anti-cancer medication, such as 6-MP.
• Parent has verbal English or Spanish fluency.
• Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure

You may not qualify if…

• Parent is unwilling or unable to follow protocol requirements

Where it is running

• Roswell Park Comprehensive Cancer Center — Buffalo, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.